The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis

Objective. To explore the influence of TNF inhibitor (TNFi) therapy and rituximab (RTX) upon the incidence of cancer in patients with RA and prior malignancy. Methods. The study population comprised RA subjects with a prior malignancy reported to the UK national cancer registers, recruited to the Br...

Full description

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford)
Main Authors: Silva-Fernández, Lucía, Lunt, Mark, Kearsley-Fleet, Lianne, Watson, Kath D., Dixon, William G., Symmons, Deborah P. M., Hyrich, Kimme L.
Format: Artigo
Language:Inglês
Published: Oxford University Press 2016
Subjects:
Clinical Science
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5088627/
https://ncbi.nlm.nih.gov/pubmed/27550304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kew314
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items